Andrew Siderowf
Active 2000–2025
- 136
- Papers
- 27,718
- Citations
- 84
- h-index
- 134
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine75.6%
- Neuroscience9.8%
- Biochemistry, Genetics and Molecular Biology5.9%
- Computer Science2.2%
- Health Professions2%
- Psychology1.9%
- Other2.6%
Topics
- Parkinson's Disease Mechanisms and Treatments19.1%
- Neurological disorders and treatments9%
- Alzheimer's disease research and treatments6.3%
- Dementia and Cognitive Impairment Research4.9%
- Amyotrophic Lateral Sclerosis Research2.1%
- Voice and Speech Disorders1.8%
- Other56.8%
Coauthors
- Daniel Weintraub62
- John Q. Trojanowski37
- Kenneth Marek36
- Tanya Simuni32
- Lana M. Chahine31
- Caroline M. Tanner30
- Christopher S. Coffey29
- Howard I. Hurtig28
- John E. Duda25
- Sharon X. Xie24
- Brit Mollenhauer23
- Alice Chen‐Plotkin22
- Danna Jennings22
- Chelsea Caspell‐Garcia21
- Karl Kieburtz21
- John Seibyl19
- Douglas Galasko18
- Leslie M. Shaw18
- Matthew B. Stern17
- Murray Grossman17
- Tatiana Foroud17
- Michael C. Brumm16
- Kathleen L. Poston15
- Andrew Singleton14
All papers
- The Parkinson Progression Marker Initiative (PPMI)
Authors: Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline M. Tanner, Tanya Simuni, Christopher S. Coffey, Karl Kieburtz, Emily Flagg, Sohini Chowdhury, Werner Poewe, Brit Mollenhauer, Paracelsus-Elena Klinik, Todd Sherer, Mark Frasier, Claire C. Meunier, Alice Rudolph, Cindy Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Ying Zhang, Arthur W. Toga, Karen Crawford, Alison B. Ansbach, Pasquale De Blasio, Michele Piovella, John Q. Trojanowski, Les Shaw, Andrew Singleton, Keith A. Hawkins, Jamie L. Eberling, Deborah W. Brooks, David Russell, Laura Leary, Stewart A. Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David G. Standaert, Stephanie Guthrie, Robert A. Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Hegeman Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly A. Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltán Mari, Melissa Gerstenhaber, David J. Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor D. Grachev, Kim P. Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony W. Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor - Progress in Neurobiology 2011 cited by 1,915
- Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Authors: Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, Carly M. Farris, Yihua Ma, Paula A. Urenia, Hieu Nguyen, Roy N. Alcalay, Lana M. Chahine, Tatiana Foroud, Douglas Galasko, Karl Kieburtz, Kalpana Merchant, Brit Mollenhauer, Kathleen L. Poston, John Seibyl, Tanya Simuni, Caroline M. Tanner, Daniel Weintraub, Aleksandar Videnović, Seung Ho Choi, Ryan Kurth, Chelsea Caspell‐Garcia, Christopher S. Coffey, Mark Frasier, Luís M. A. Oliveira, Samantha J. Hutten, Todd Sherer, Kenneth Marek, Claudio Soto - The Lancet Neurology 2023 cited by 693
- A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Authors: Tanya Simuni, Lana M. Chahine, Kathleen L. Poston, Michael C. Brumm, Teresa Buracchio, Michelle Campbell, Sohini Chowdhury, Christopher S. Coffey, Luis Concha‐Marambio, Tien Dam, Peter DiBiaso, Tatiana Foroud, Mark Frasier, Caroline Gochanour, Danna Jennings, Karl Kieburtz, Catherine Kopil, Kalpana Merchant, Brit Mollenhauer, Thomas J. Montine, Kelly Nudelman, Gennaro Pagano, John Seibyl, Todd Sherer, Andrew Singleton, Diane Stephenson, Matthew Stern, Claudio Soto, Caroline M. Tanner, Eduardo Tolosa, Daniel Weintraub, Yuge Xiao, Andrew Siderowf, Billy Dunn, Kenneth Marek - The Lancet Neurology 2024 cited by 563
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
Authors: John Robinson, Edward B. Lee, Sharon X. Xie, Lior Rennert, EunRan Suh, Colin Bredenberg, Carrie Caswell, Vivianna M. Van Deerlin, Ning Yan, Ahmed H. Yousef, Howard I. Hurtig, Andrew Siderowf, Murray Grossman, Corey T. McMillan, Bruce L. Miller, John E. Duda, David J. Irwin, David A. Wolk, Lauren Elman, Leo McCluskey, Alice Chen‐Plotkin, Daniel Weintraub, Steven E. Arnold, Johannes Brettschneider, Virginia M.‐Y. Lee, John Q. Trojanowski - Brain 2018 cited by 737
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
Authors: Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Tanya Simuni, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer, the Parkinson's Progression Markers Initiative - Annals of Clinical and Translational Neurology 2018 cited by 686
- Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
Authors: E. Ray Dorsey, Radu Constantinescu, James P. Thompson, Kevin Biglan, Robert G. Holloway, Karl Kieburtz, Fred Marshall, Bernard Ravina, Giovanni Schifitto, Andrew Siderowf, Caroline M. Tanner - Neurology 2006 cited by 2,464
- Trial of Cinpanemab in Early Parkinson’s Disease
Authors: Anthony E. Lang, Andrew Siderowf, Eric A. Macklin, Werner Poewe, David J. Brooks, Hubert H. Fernandez, Olivier Rascol, Nir Giladi, Fabrizio Stocchi, Caroline M. Tanner, Ronald B. Postuma, David K. Simon, Eduardo Tolosa, Brit Mollenhauer, Jesse M. Cedarbaum, Kyle Fraser, James Xiao, Karleyton C. Evans, Danielle Graham, Inbal Sapir, Jennifer Inra, R. Matthew Hutchison, Minhua Yang, Tara Fox, Samantha Budd Haeberlein, Tien Dam - New England Journal of Medicine 2022 cited by 333
- Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
Authors: Staci Hoops, Sarra Nazem, Andrew Siderowf, John E. Duda, Sharon X. Xie, M. B. Stern, Daniel Weintraub - Neurology 2009 cited by 1,282
- Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
Authors: Adam Fleisher, Michael J. Pontecorvo, Michael D. Devous, Ming‐Chi Lu, Anupa Arora, Stephen P. Truocchio, Patricia Aldea, Matthew Flitter, Tricia Locascio, Marybeth Devine, Andrew Siderowf, Thomas G. Beach, Thomas J. Montine, Geidy E. Serrano, Craig Curtis, Allison Perrin, Stephen Salloway, Misty Daniel, Charles Wellman, Abhinay D. Joshi, David J. Irwin, Val J. Lowe, William W. Seeley, Miloš D. Ikonomović, Joseph C. Masdeu, Ian Kennedy, Thomas S. Harris, Michael Navitsky, Sudeepti Southekal, Mark A. Mintun, A16 Study Investigators - JAMA Neurology 2020 cited by 443
- Neuro-QOL
Authors: David Cella, Jin‐Shei Lai, Cindy J. Nowinski, David Victorson, Amy H. Peterman, Deborah Miller, François Béthoux, Allen W. Heinemann, Susan Rubin, José E Cavazos, Anthony T. Reder, Robert Sufit, Tanya Simuni, Gregory L. Holmes, Andrew Siderowf, Valerie Wojna, Rita Bode, Natalie McKinney, Tracy Podrabsky, Katy Wortman, Seung W. Choi, Richard Gershon, Nan Rothrock, Claudia S. Moy - Neurology 2012 cited by 780
- Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
Authors: Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry, Jennifer C. Sasaki, René Meisner, Dolores Diaz, Hilda Solanoy, Xiang Wang, Elvira Negrou, Vitaliy V. Bondar, Rajarshi Ghosh, Michael T. Maloney, Nicholas E. Propson, Yuda Zhu, Romeo Maciuca, Laura Harris, Angela Kay, Peter A. LeWitt, T. Alex King, Drew S. Kern, Aaron Ellenbogen, Ira Goodman, Andrew Siderowf, Jason Aldred, Omid Omidvar, Shababa T. Masoud, Sonnet S. Davis, Annie Arguello, Anthony A. Estrada, Javier de Vicente, Zachary K. Sweeney, Giuseppe Astarita, Marie T. Borin, Bradley K. Wong, Harvey Wong, Hoang N. Nguyen, Kimberly Scearce‐Levie, Carole Ho, Matthew D. Troyer - Science Translational Medicine 2022 cited by 252
- Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
Authors: Whitley W. Aamodt, Teresa Waligórska, Junchao Shen, Thomas F. Tropea, Andrew Siderowf, Daniel Weintraub, Murray Grossman, David J. Irwin, David A. Wolk, Sharon X. Xie, John Q. Trojanowski, Leslie M. Shaw, Alice Chen‐Plotkin - Movement Disorders 2021 cited by 177
- A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
Authors: The Parkinson Study Group QE3 Investigators, M. Flint Beal, David Oakes, Ira Shoulson, Claire Henchcliffe, Wendy R. Galpern, Richard Haas, Jorge L. Juncos, John G. Nutt, Tiffini Voss, Bernard Ravina, Clifford M. Shults, Karen Helles, Victoria Snively, Mark Lew, Brian Griebner, Arthur Watts, Shan Gao, Emmanuelle Pourcher, Louisette Bond, Katie Kompoliti, Pinky Agarwal, Cherissa Sia, Mandar Jog, Linda Cole, Munira Sultana, Roger Kurlan, Irene Hegeman Richard, Cheryl Deeley, Cheryl Waters, Angel Figueroa, Ani Arkun, Matthew Brodsky, William G. Ondo, Christine Hunter, Joohi Jimenez‐Shahed, Alicia Palao, Janis M. Miyasaki, Julie So, James W. Tetrud, Liza Reys, Katharine Smith, Carlos Singer, Anita Blenke, David Russell, Candace Cotto, Joseph H. Friedman, Margaret C. Lannon, Lin Zhang, Edward Drasby, Rajeev Kumar, Thyagarajan Subramanian, Donna Stuppy Ford, David A. Grimes, Diane Côté, Jennifer Conway, Andrew Siderowf, Marian L. Evatt, Barbara Sommerfeld, Abraham Lieberman, Michael S. Okun, Ramon L. Rodriguez, Stacy Merritt, Camille Swartz, W. R. Wayne Martin, Pamela King, Natividad Stover, Stephanie Guthrie, Ray L. Watts, Anwar Ahmed, Hubert H. Fernandez, Adrienna Winters, Zoltán Mari, Ted M. Dawson, Becky Dunlop, Andrew Feigin, Barbara Shannon, Melissa J. Nirenberg, Mattson Ogg, Samuel A. Ellias, Cathi-Ann Thomas, Karen Frei, Iván Bódis-Wollner, Sofya Glazman, Thomas A. Mayer, Robert A. Hauser, Rajesh Pahwa, April Langhammer, Ranjit Ranawaya, Lorelei Derwent, Kapil D. Sethi, Buff Farrow, Rajan Prakash, Irene Litvan, Annette Robinson, Alok Sahay, Maureen Gartner, Vanessa K. Hinson, Samuel Markind, Melisa Pelikan and 62 more - JAMA Neurology 2014 cited by 395
- Questionnaire for impulsive‐compulsive disorders in Parkinson's Disease–Rating Scale
Authors: Daniel Weintraub, Eugenia Mamikonyan, Kimberly Papay, Judith A. Shea, Sharon X. Xie, Andrew Siderowf - Movement Disorders 2011 cited by 384
- Proposal for a Biologic Staging System of Parkinson’s Disease
Authors: Lana M. Chahine, Kalpana Merchant, Andrew Siderowf, Todd Sherer, Caroline M. Tanner, Kenneth Marek, Tanya Simuni - Journal of Parkinson s Disease 2023 cited by 85
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Authors: Brit Mollenhauer, Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg, Sebastian Schade, Roland G. Gera, Wenting Wang, Feng Gao, Mark Frasier, Lana M. Chahine, Christopher S. Coffey, Andrew Singleton, Tanya Simuni, Daniel Weintraub, John Seibyl, Arthur W. Toga, Caroline M. Tanner, Karl Kieburtz, Kenneth Marek, Andrew Siderowf, Jesse M. Cedarbaum, Samantha J. Hutten, Claudia Trenkwalder, Danielle Graham - Movement Disorders 2020 cited by 201
- Impulse Control Disorders in Parkinson Disease
Authors: Daniel Weintraub, Juergen Koester, Marc N. Potenza, Andrew Siderowf, Mark Stacy, Valerie Voon, Jacqueline Whetteckey, Glen Wunderlich, Anthony E. Lang - Archives of Neurology 2010 cited by 1,462
- Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Authors: Tanya Simuni, Andrew Siderowf, Shirley Lasch, Christopher S. Coffey, Chelsea Caspell‐Garcia, Danna Jennings, Caroline M. Tanner, John Q. Trojanowski, Leslie M. Shaw, John Seibyl, Norbert Schuff, Andrew Singleton, Karl Kieburtz, Arthur W. Toga, Brit Mollenhauer, Doug Galasko, Lana M. Chahine, Daniel Weintraub, Tatiana Foroud, Duygu Tosun, Kathleen L. Poston, Vanessa Arnedo, Mark Frasier, Todd Sherer, Sohini Chowdhury, Kenneth Marek, the Parkinson's Progression Marker Initiative* - Movement Disorders 2018 cited by 205
- Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
Authors: Daniel Weintraub, Staci Hoops, Judy A. Shea, Kelly E. Lyons, Rajesh Pahwa, Erika Driver‐Dunckley, Charles H. Adler, Marc N. Potenza, Janis M. Miyasaki, Andrew Siderowf, John E. Duda, Howard I. Hurtig, Amy Colcher, Stacy Horn, Matthew B. Stern, Valerie Voon - Movement Disorders 2009 cited by 531
- Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases
Authors: Hanae Nakashima‐Yasuda, Kunihiro Uryu, John Robinson, Sharon X. Xie, Howard I. Hurtig, John E. Duda, Steven E. Arnold, Andrew Siderowf, Murray Grossman, James B. Leverenz, Randy Woltjer, Oscar L. López, Ronald L. Hamilton, Debby W. Tsuang, Douglas Galasko, Eliezer Masliah, Jeffrey Kaye, Christopher M. Clark, Thomas J. Montine, Virginia M.‐Y. Lee, John Q. Trojanowski - Acta Neuropathologica 2007 cited by 467
- Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
Authors: David G. Coughlin, Sharon X. Xie, Mendy Liang, Andrew Williams, Claire Peterson, Daniel Weintraub, Corey T. McMillan, David A. Wolk, Rizwan Akhtar, Howard I. Hurtig, H. Branch Coslett, Roy H. Hamilton, Andrew Siderowf, John E. Duda, Katya Rascovsky, Edward B. Lee, Virginia M.‐Y. Lee, Murray Grossman, John Q. Trojanowski, David J. Irwin - Annals of Neurology 2018 cited by 146
- Phosphorylated α-Synuclein in Parkinson’s Disease
Authors: Yu Wang, Min Shi, Kathryn A. Chung, Cyrus P. Zabetian, James B. Leverenz, Daniela Berg, Karin Srulijes, John Q. Trojanowski, Virginia M.‐Y. Lee, Andrew Siderowf, Howard I. Hurtig, Irene Litvan, Mya C. Schiess, Elaine R. Peskind, M. Masuda, Masato Hasegawa, Xiangmin Lin, Catherine Pan, Douglas Galasko, David S. Goldstein, Poul Henning Jensen, Hui Yang, Kevin C. Cain, Jing Zhang - Science Translational Medicine 2012 cited by 277
- Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
Authors: Michael C. Brumm, Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell‐Garcia, Lana M. Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Galasko, Kalpana Merchant, Vanessa Arnedo, Samantha J. Hutten, Alyssa O’Grady, Kathleen L. Poston, Caroline M. Tanner, Daniel Weintraub, Karl Kieburtz, Kenneth Marek, Christopher S. Coffey, on behalf of the Parkinson’s Progression Markers Initiative - Journal of Parkinson s Disease 2023 cited by 65
- CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
Authors: Andrew Siderowf, Sharon X. Xie, Howard I. Hurtig, Daniel Weintraub, John E. Duda, Alice Chen‐Plotkin, Leslie M. Shaw, Vivianna M. Van Deerlin, John Q. Trojanowski, C. Clark - Neurology 2010 cited by 380
